Publication of the data concerning relationships between companies and medical practitioners: Responsible Transparency
From June 30, the data will be available on our website concerning both the relationships of collaboration during 2015 between Alfa Wassermann S.p.A. and Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs), and Research and Development (R&D).
Absolute transparency through the publication of this data was the choice made by pharmaceutical companies with complete conviction, adopting Farmindustria's Code on Disclosure in implementation of the EFPIA (European Federation of Pharmaceutical Industries and Associations) Code.
The collaboration between the pharmaceutical companies and medical practitioners, which has been extremely well-regulated for some time, can be broken down into various spheres of activity:
- research and development of new medicines through clinical trials conducted in hospitals, universities and public and private health facilities;
- scientific consultancy;
- seminars and scientific conventions that provide information and updates;
- support for CME (Continuing Medical Education) conferences and courses organised by public institutions, universities, scientific societies and accredited CME providers.
It is the exchange of knowledge between companies and medical practitioners, with their wealth of know-how and experience in the field, that allows information to be collected that is useful in research and development, and thereby make available increasingly efficacious medicines to meet the health needs of patients.
These relationships, in addition to being governed by national and international regulations, are based on reciprocal respect for the roles within a transparent framework of the ethical standards of Farmindustria, which lay down strict controls performed in accordance with the precise procedures dictated by third-party bodies, presided over by judges appointed by the President of the Court of Cassation.
You can access the data - published in complete accordance with the Italian regulations on privacy - concerning individual professionals who have signed the agreement and, in aggregate form, all the others.
NOTE ON ACCOUNTING ASPECTS
The figures published are recorded in compliance with VAT regulations in force. They are presented without VAT and according to the principle of cash. Figures in foreign currencies are converted into Euros at the exchange rate current as of the date of recording.
Further information on the new regulatory provisions introduced with the "Code on Disclosure of Transfers of Value From Pharmaceutical Companies to Healthcare Professionals and Healthcare Organizations" are available from the www.farmindustria.it website (Home/Code of Ethics page).